Bicarbonate

Bicarbonate

SCHEMBL6553065

O=C(O)O.[N-]=[N+]=N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL1908229 1.00 CA1 (0.55)
Bicarbonate SCHEMBL5332176 1.00 CA1 (0.55)
Oxalic Acid SCHEMBL6254640 0.84 CA1 (0.46)
Acetic Acid SCHEMBL18063116 0.84
Carbamic Acid SCHEMBL5990476 0.84
Acetic Acid SCHEMBL10828286 0.81 FFAR3 (0.50)
Carbamic Acid SCHEMBL16013541 0.81 ACHE (0.50)
Bicarbonate SCHEMBL8020328 0.80
Bicarbonate SCHEMBL28201863 0.80
SCHEMBL6526159 0.78 CA1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731838-B1 BINDING STRUCTURES DIRECTED AGAINST THE CA55.1 ANTIGEN ASTRAZENECA AB (SE) 2004-02-18 EP disclosed
US-20030138791-A1 3-Spiro-cyanin fluorochromes and their use in bioassays HAALCK LUTZ (DE) 2003-07-24 US disclosed
JP-2000086639-A SYNTHESIS OF CYTOXAZONE INST OF PHYSICAL & CHEMICAL RES 2000-03-28 JP disclosed
US-5665357-A CANCER THERAPY ZENECA LIMITED (GB) 1997-09-09 US disclosed
EP-0731838-A1 BINDING STRUCTURES DIRECTED AGAINST THE CA55.1 ANTIGEN ZENECA LIMITED (GB) 1996-09-18 EP disclosed
WO-1995015382-A1 BINDING STRUCTURES DIRECTED AGAINST THE CA55.1 ANTIGEN ZENECA LIMITED (GB) 1995-06-08 WO disclosed
US-4234578-A ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1980-11-18 US disclosed